Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03740542
Other study ID # STUDY19020375
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 27, 2018
Est. completion date January 2025

Study information

Verified date February 2024
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research study is a phase III randomized trial to study the value of the addition of a pyloroplasty procedure versus no pyloroplasty procedure during the performance of esophagectomy. Pyloroplasty is a type of pyloric drainage procedure.


Description:

Patients selected for enrollment in this study will be adults (18-85 years of age) that have been scheduled for exploration, and possible esophagectomy. Prior to surgery, patients will be randomized to one of two groups. Group A will have a pyloroplasty performed as part of the esophagectomy procedure. Group B will not have a pyloroplasty performed. Postoperative patient outcomes will be assessed for 24 months.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 140
Est. completion date January 2025
Est. primary completion date February 14, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Subjects must be willing to undergo esophagectomy for benign or malignant condition - Women and men 18-85 years of age - Eastern Cooperative Oncology Group (ECOG) performance status 0-2 - Stomach is used as conduit Exclusion Criteria: - Previous operations of the pylorus - Previous gastric resection - Previous gastric bypass - Patients who are unable to tolerate surgery - Participants may be enrolled and randomized on the study but may be excluded at the time of the surgery because of findings by the surgeon that preclude performing esophagectomy, or using stomach as a conduit or findings which preclude following the randomized arm. - Age <18 years of age or > 85 years of age - BMI > 50 - Liver cirrhosis or liver failure at physician's discretion

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Esophagectomy
Surgical removal of part of esophagus
Pyloroplasty
pyloric drainage procedure

Locations

Country Name City State
United States Department of Cardiothoracic Surgery Pittsburgh Pennsylvania
United States University of Pittsburgh Medical Center Presbyterian-Shadyside Hospital Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary pneumonia Defined as meeting 3 of 5 characteristics: fever, leukocytosis, chest x-ray (CXR) with infiltrate, positive culture from sputum, or treatment with antibiotics 30 days postoperatively
Primary esophageal anastomosis leak requiring surgery Defined as a leak at the esophageal anastomosis site as evidenced by Barium Swallow Study. 30 days postoperatively
Secondary Mortality Death within 30 days of surgery 30 days
Secondary Time to start oral diet Number of days from surgery to starting oral diet Up to 24 months
Secondary Quality of life assessment by completion of SF36 Quality of Life questionnaire SF36 Quality of Life questionnaire Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery
Secondary Gastroesophageal Reflux Disease (GERD)-Health Related Quality of Life (HRQL) measured by completion of GERD HRQL questionnaire Gastroesophageal Reflux Disease (GERD)-Health Related Quality of Life (HRQL) questionnaire prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery. Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery.
Secondary Dysphagia as reported by patient using the Dysphagia scale Dysphagia scale measures swallowing difficulty on a scale of 1-5. (1=no difficulty swallowing; 2=difficulty swallowing hard solids; 3=difficulty swallowing soft solids; 4=difficulty swallowing liquids; 5=unable to swallow anything. A lower score represents a better outcome. Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery.
Secondary Nasogastric tube drainage measured in milliliters Measured in milliliters From date of surgery until date nasogastric tube is removed or date of discharge from hospital, whichever came first, assessed up to 24 months.
Secondary Replacement of nasogastric tube reported as number of days from tube removal to reinsertion Number of days from nasogastric tube removal to reinsertion Up to 24 months
Secondary Esophageal dilations reported as the number of esophageal dilations performed Number of esophageal dilations performed Up to 24 months
Secondary Length of hospital stay Number of days in hospital From date of surgery until the date of discharge from hospital, assessed up to 24 months.
Secondary Aspiration as reported on radiographic imaging Radiographic imaging reports Performed when clinically indicated up to 24 months postoperatively
Secondary Gastric outlet obstruction as reported on barium swallow reports Barium swallow reports Performed when clinically indicated up to 24 months postoperatively
Secondary Re-admission to hospital Number of days from hospital discharge to re-admission Up to 24 months postoperatively
Secondary Unexpected return to the Operating Room Procedure performed in the Operating Room Up to 24 months postoperatively
Secondary Esophageal anastomotic leak not requiring surgery Barium swallow reports Performed when clinically indicated up to 24 months postoperatively
Secondary Respiratory complications other than pneumonia Radiographic imaging reports Performed when clinically indicated up to 24 months postoperatively
See also
  Status Clinical Trial Phase
Completed NCT00827931 - Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery Phase 4
Completed NCT00420017 - Prevention of Atrial Fibrillation Following Esophagectomy Phase 4
Recruiting NCT04750096 - Esophagectomy Enhanced Recovery After Surgery Protocol
Not yet recruiting NCT06147180 - Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Recruiting NCT03835273 - Oesophagectomy and Chest Wall and Respiratory Function
Enrolling by invitation NCT02086461 - Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay N/A
Recruiting NCT00260559 - Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Recruiting NCT02017002 - Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer N/A
Recruiting NCT04654975 - Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
Recruiting NCT04008420 - The Association of Intraoperative Oxygen Reserve Index and Postoperative Pulmonary Complications in Robot-assisted Esophagectomy
Recruiting NCT01144325 - Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position Phase 2
Completed NCT01169051 - A Retrospective Analysis of Statin Use and Outcome After Thoracic Cancer Surgery N/A
Recruiting NCT05950438 - Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
Not yet recruiting NCT06271707 - Stellate Ganglion Block Phase 4
Recruiting NCT02418052 - Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE N/A
Completed NCT02158286 - Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet N/A
Recruiting NCT02309619 - Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE N/A
Completed NCT05604950 - Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
Completed NCT00708513 - Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations. N/A
Recruiting NCT02530983 - Mayo Clinic Upper Digestive Disease Survey